Jesús Rodríguez-Baño spends much of his time researching Microbiology, Internal medicine, Antibiotic resistance, Bacteremia and Escherichia coli. His research integrates issues of Molecular epidemiology, Genotype and Enterobacteriaceae in his study of Microbiology. In his study, Beta-Lactamase Inhibitors is inextricably linked to Carbapenem, which falls within the broad field of Internal medicine.
His Antibiotic resistance research incorporates elements of Disease, Proa and Public health. His Bacteremia study also includes
Jesús Rodríguez-Baño mostly deals with Internal medicine, Microbiology, Intensive care medicine, Bacteremia and Antibiotic resistance. His work deals with themes such as Enterobacteriaceae, Escherichia coli, Acinetobacter baumannii and Virulence, which intersect with Microbiology. In his study, which falls under the umbrella issue of Intensive care medicine, Incidence and Infection control is strongly linked to Epidemiology.
The study incorporates disciplines such as Sepsis, Mortality rate and Staphylococcal infections, Vancomycin, Staphylococcus aureus in addition to Bacteremia. His Antibiotic resistance research includes elements of Psychological intervention, Drug resistance, Public health and Environmental health. His Prospective cohort study research focuses on Proportional hazards model and how it relates to Propensity score matching and Hazard ratio.
Jesús Rodríguez-Baño mainly focuses on Internal medicine, Antibiotics, Antibiotic resistance, Microbiology and Prospective cohort study. Jesús Rodríguez-Baño works mostly in the field of Internal medicine, limiting it down to topics relating to Klebsiella pneumoniae and, in certain cases, Bacteremia, Framingham Risk Score and In vitro. His studies deal with areas such as Infectious disease, Antimicrobial and Incidence as well as Antibiotics.
His Antibiotic resistance research integrates issues from Transmission, Epidemiology, Dosing and Intensive care medicine. The various areas that Jesús Rodríguez-Baño examines in his Microbiology study include Acinetobacter baumannii and Escherichia coli. He has included themes like Blood culture, Etiology and Risk factor in his Prospective cohort study study.
The scientist’s investigation covers issues in Internal medicine, Antibiotics, Antibiotic resistance, Confidence interval and Klebsiella pneumoniae. Jesús Rodríguez-Baño combines subjects such as Bacteremia and Fosfomycin with his study of Internal medicine. Jesús Rodríguez-Baño interconnects Pseudomonas aeruginosa, Acinetobacter baumannii and Drug resistance in the investigation of issues within Antibiotics.
His studies deal with areas such as Environmental health, Epidemiology and Dosing as well as Antibiotic resistance. His Klebsiella pneumoniae study integrates concerns from other disciplines, such as Microbiology and Sepsis. His work carried out in the field of Microbiology brings together such families of science as Gram and In vivo.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis.
Evelina Tacconelli;Elena Carrara;Alessia Savoldi;Stephan Harbarth.
Lancet Infectious Diseases (2017)
The global threat of antimicrobial resistance: science for intervention
Ignasi Roca;Murat Akova;F. Baquero;Jean Carlet.
new microbes and new infections (2015)
Epidemiology and Clinical Features of Infections Caused by Extended-Spectrum Beta-Lactamase-Producing Escherichia coli in Nonhospitalized Patients
Jesús Rodríguez-Baño;Maria Dolores Navarro;Luisa Romero;Luis Martínez-Martínez.
Journal of Clinical Microbiology (2004)
ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients
E. Tacconelli;M.A. Cataldo;S.J. Dancer;G. De Angelis.
Clinical Microbiology and Infection (2014)
A Multinational Survey of Risk Factors for Infection with Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Nonhospitalized Patients
Ronen Ben-Ami;Jesús Rodríguez-Baño;Hande Arslan;Johann D D Pitout.
Clinical Infectious Diseases (2009)
Community Infections Caused by Extended-Spectrum β-Lactamase–Producing Escherichia coli
Jesús Rodríguez-Baño;Juan C. Alcalá;Jose M. Cisneros;Fabio Grill.
JAMA Internal Medicine (2008)
Global dissemination of a multidrug resistant Escherichia coli clone
Nicola K. Petty;Nouri L. Ben Zakour;Mitchell Stanton-Cook;Elizabeth Skippington.
Proceedings of the National Academy of Sciences of the United States of America (2014)
Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae.
Jesús Rodríguez-Baño;Belén Gutiérrez-Gutiérrez;Isabel Machuca;Alvaro Pascual.
Clinical Microbiology Reviews (2018)
Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment
J.M. Cisneros;J. Rodríguez-Baño.
Clinical Microbiology and Infection (2002)
β-Lactam/β-Lactam Inhibitor Combinations for the Treatment of Bacteremia Due to Extended-Spectrum β-Lactamase–Producing Escherichia coli: A Post Hoc Analysis of Prospective Cohorts
Jesús Rodríguez-Baño;María Dolores Navarro;Pilar Retamar;Encarnación Picón.
Clinical Infectious Diseases (2012)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: